BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 10363850)

  • 21. Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies.
    Stram DO; Matthay KK; O'Leary M; Reynolds CP; Haase GM; Atkinson JB; Brodeur GM; Seeger RC
    J Clin Oncol; 1996 Sep; 14(9):2417-26. PubMed ID: 8823319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
    Goto S; Umehara S; Gerbing RB; Stram DO; Brodeur GM; Seeger RC; Lukens JN; Matthay KK; Shimada H
    Cancer; 2001 Nov; 92(10):2699-708. PubMed ID: 11745206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central nervous system metastases in neuroblastoma: radiologic, clinical, and biologic features in 23 patients.
    Matthay KK; Brisse H; Couanet D; Couturier J; Bénard J; Mosseri V; Edeline V; Lumbroso J; Valteau-Couanet D; Michon J
    Cancer; 2003 Jul; 98(1):155-65. PubMed ID: 12833468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of circulating tumor cells and bone marrow micrometastasis in advanced neuroblastoma.
    Kuroda T; Morikawa N; Matsuoka K; Fujino A; Honna T; Nakagawa A; Kumagai M; Masaki H; Saeki M
    J Pediatr Surg; 2008 Dec; 43(12):2182-5. PubMed ID: 19040931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stage III neuroblastoma over 1 year of age at diagnosis: improved survival with intensive multimodality therapy including multiple alkylating agents.
    West DC; Shamberger RC; Macklis RM; Kozakewich HP; Wayne AS; Kreissman SG; Korf BR; Lavally B; Grier HE
    J Clin Oncol; 1993 Jan; 11(1):84-90. PubMed ID: 8418247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percentage tumor necrosis following chemotherapy in neuroblastoma correlates with MYCN status but not survival.
    Bomken S; Davies B; Chong L; Cole M; Wood KM; McDermott M; Tweddle DA
    Pediatr Hematol Oncol; 2011 Mar; 28(2):106-14. PubMed ID: 21214410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of urokinase plasminogen activator and its receptor in metastasis and invasion of neuroblastoma.
    Li P; Gao Y; Ji Z; Zhang X; Xu Q; Li G; Guo Z; Zheng B; Guo X
    J Pediatr Surg; 2004 Oct; 39(10):1512-9. PubMed ID: 15486896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indolent course of advanced neuroblastoma in children older than 6 years at diagnosis.
    Blatt J; Gula MJ; Orlando SJ; Finn LS; Misra DN; Dickman PS
    Cancer; 1995 Sep; 76(5):890-4. PubMed ID: 8625194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stage IV neuroblastoma in infants. Long-term survival.
    Paul SR; Tarbell NJ; Korf B; Kretschmar CS; Lavally B; Grier HE
    Cancer; 1991 Mar; 67(6):1493-7. PubMed ID: 2001536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CXCR4 expression in neuroblastoma primary tumors is associated with clinical presentation of bone and bone marrow metastases.
    Russell HV; Hicks J; Okcu MF; Nuchtern JG
    J Pediatr Surg; 2004 Oct; 39(10):1506-11. PubMed ID: 15486895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Orbital Metastasis Is Associated With Decreased Survival in Stage M Neuroblastoma.
    Harreld JH; Bratton EM; Federico SM; Li X; Grover W; Li Y; Kerr NC; Wilson MW; Hoehn ME
    Pediatr Blood Cancer; 2016 Apr; 63(4):627-33. PubMed ID: 26599346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk stratification of high-risk metastatic neuroblastoma: A report from the HR-NBL-1/SIOPEN study.
    Morgenstern DA; Pötschger U; Moreno L; Papadakis V; Owens C; Ash S; Pasqualini C; Luksch R; Garaventa A; Canete A; Elliot M; Wieczorek A; Laureys G; Kogner P; Malis J; Ruud E; Beck-Popovic M; Schleiermacher G; Valteau-Couanet D; Ladenstein R
    Pediatr Blood Cancer; 2018 Nov; 65(11):e27363. PubMed ID: 30015396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between histopathological features, MYCN amplification, and prognosis: a UKCCSG study. United Kingdom Children Cancer Study Group.
    George RE; Variend S; Cullinane C; Cotterill SJ; McGuckin AG; Ellershaw C; Lunec J; Pearson AD;
    Med Pediatr Oncol; 2001 Jan; 36(1):169-76. PubMed ID: 11464876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of clinical and biologic features in Stage 3 neuroblastoma: a report from the International Neuroblastoma Risk Group project.
    Meany HJ; London WB; Ambros PF; Matthay KK; Monclair T; Simon T; Garaventa A; Berthold F; Nakagawara A; Cohn SL; Pearson AD; Park JR
    Pediatr Blood Cancer; 2014 Nov; 61(11):1932-9. PubMed ID: 25044743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors in metastatic neuroblastoma in patients over 1 year of age treated with high-dose chemotherapy and stem cell transplantation: a multivariate analysis in 218 patients treated in a single institution.
    Hartmann O; Valteau-Couanet D; Vassal G; Lapierre V; Brugières L; Delgado R; Couanet D; Lumbroso J; Benhamou E
    Bone Marrow Transplant; 1999 Apr; 23(8):789-95. PubMed ID: 10231141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: is cure possible in a small subgroup?
    Philip T; Zucker JM; Bernard JL; Lutz P; Bordigoni P; Plouvier E; Robert A; Roché H; Souillet G; Bouffet E
    J Clin Oncol; 1991 Jun; 9(6):1037-44. PubMed ID: 2033417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas.
    Suzuki T; Bogenmann E; Shimada H; Stram D; Seeger RC
    J Natl Cancer Inst; 1993 Mar; 85(5):377-84. PubMed ID: 8433391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of early metastatic response by 123I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastoma.
    Matthay KK; Edeline V; Lumbroso J; Tanguy ML; Asselain B; Zucker JM; Valteau-Couanet D; Hartmann O; Michon J
    J Clin Oncol; 2003 Jul; 21(13):2486-91. PubMed ID: 12829667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroblastoma in adolescents: the Italian experience.
    Conte M; Parodi S; De Bernardi B; Milanaccio C; Mazzocco K; Angelini P; Viscardi E; Di Cataldo A; Luksch R; Haupt R
    Cancer; 2006 Mar; 106(6):1409-17. PubMed ID: 16475209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The recurrence patterns of stages I, II and III neuroblastoma: experience with 77 relapsing patients.
    Berthold F; Hero B; Breu H; Christiansen H; Erttmann R; Gnekow A; Herrmann F; Klingebiel T; Lampert F; Müller-Weihrich S; Weinel P
    Ann Oncol; 1996 Feb; 7(2):183-7. PubMed ID: 8777176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.